5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

      1 , , ,
      Diabetes care

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The objective of the study was to assess the efficacy and safety of four fixed doses of nateglinide compared with placebo in the treatment of patients with type 2 diabetes with focus on the prandial state.

          Related collections

          Author and article information

          Journal
          Diabetes Care
          Diabetes care
          0149-5992
          0149-5992
          Feb 2000
          : 23
          : 2
          Affiliations
          [1 ] Outpatient Department, Institute of Clinical Metabolic Research, Medical Faculty, Technical University of Dresden, Germany.
          Article
          10868832
          4483f16c-b130-4f1a-bcb8-976e9cc2a659

          Comments

          Comment on this article